TherOZap™

Next Generation Thermal Therapy Insect Device

Mosquitos, bees, spiders, mites, and jellyfish love to bite or sting! Unfortunately, attacks from these, and other pests, may leave us with painful, itchy and inflamed skin- or worse yet a nasty virus!

Therma Bright Inc. received FDA approval for its first-generation insect device as a Class II medical device for the relief of the symptoms of pain, itch and inflammation associated with insect bites and stings.

Introducing TherOZap™ – the next generation thermal therapy insect device. The TherOZap™ thermal therapy will aim to reduce the inflammatory response, relieving the symptoms of pain, itch and inflammation associated with insect bites and stings.

Currently, Therma Bright has been working with engineers and designers to complete a prototype that will be tested for effectiveness against the Zika virus and other mosquito borne diseases.  Once testing is complete Therma Bright will seek any regulatory approvals and outsource manufacturing and distribute TherOZap™ through distribution partners and online through social media channels.